Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Selective and compartmentalized myelin expression of HspB5.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Defining the microglia response during the time course of chronic neurodegeneration.
Control devices for electrically powered wheelchairs: prevalence, defining characteristics and user perspectives.
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
Changes in Multidigit Synergies and Their Feed-Forward Adjustments in Multiple Sclerosis.
Paraquat induces peripheral myelin disruption and locomotor defects: crosstalk with LXR and Wnt pathways.
Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels.
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.
[Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
Gray matter-related proteins are associated with childhood-onset multiple sclerosis.
Amelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein.
Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific.
Phenytoin for neuroprotection - Authors' reply.
Immunogenetics of multiple sclerosis: more questions than answers.
Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.
Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29.
Learning to live with multiple sclerosis cognitive impairment and how it influences readiness for group cognitive intervention.
Focal Injection of Ethidium Bromide as a Simple Model to Study Cognitive Deficit and Its Improvement.
Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.
Dopa-responsive acute disseminated encephalomyelitis with marked atrophy of the striate body.
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.
SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.

Pages